Results 271 to 280 of about 127,081 (303)
Some of the next articles are maybe not open access.
Matrix metalloproteinase inhibitors.
IDrugs : the investigational drugs journal, 2010The Division of Medicinal Chemistry offered a number of sub-sessions including this one on matrix metalloproteinase (MMP) inhibitors. The overexpression of matrix metalloproteinases has been associated with cancer malignancy, arthritis and several immune system-related infectious diseases such as sepsis.
openaire +1 more source
Matrix Metalloproteinase Inhibitors in Arthritis
Journal of Enzyme Inhibition, 1998K M, Bottomley +2 more
openaire +2 more sources
Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
International Journal of Molecular Sciences, 2023Sanaa K Bardaweel
exaly
Matrix metalloproteinases and their inhibitors.
Anticancer research, 1999Degradation of the extracellular matrix around tumour cells is an essential step in the process of tumour invasion and metastasis. The family of structurally related metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMP), play an important role in matrix degradation by tumour cells. In this paper MMP and TIMP
openaire +1 more source
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Nature Reviews Drug Discovery, 2007Jialiang Hu +2 more
exaly
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
European Journal of Medicinal Chemistry, 2020Nilanjan Adhikari +2 more
exaly